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Abstract
Cardiac sarcoidosis (CS) is increasingly recognized as a cause of diverse cardiac manifestations. Spontaneous coronary
artery dissection (SCAD) has emerged as an important cause of acute coronary syndrome especially among young females.
The prevalence of sarcoidosis in the causal spectrum of SCAD has not been described before but sarcoidosis is cited as a
potential yet rare cause of SCAD. We aimed to examine the frequency and characteristics of SCAD in CS. Searching two
prospective CS registries with 481 CS patients, we found only one case of manifest SCAD. She is a 61-year-old female
previously diagnosed with endomyocardial biopsy confirmed CS. She presented with chest pain and elevated troponin.
Coronary angiogram revealed two-vessel SCAD. Fluorodeoxyglucose positron emission tomography scan showed likely
reactivation of CS. The patient was treated with dual antiplatelet therapy and immunosuppression. Repeat angiogram
showed complete resolution of the coronary lesions.
INTRODUCTION
Spontaneous coronary artery dissection (SCAD) is defined as
separation of the artery wall layers (intima, media and adven-
titia) without traumatic or iatrogenic cause [1]. Pathologically,
SCAD can result from either an intramural hemorrhage in the
arterial wall from ruptured vasa vasorum or intimal tear. SCAD
is associated with arteriopathies that lead to inflammation,
degeneration and stress in the arterial walls; fibromuscular
dysplasia; systemic inflammatory diseases; connective tissue
diseases; coronary spasm; pregnancy-hormonal related factors;
etc [1, 2].
Typically presenting as an acute coronary syndrome (ACS),
SCAD is often managed conservatively [1–5]. Smaller proportion
of patients manifest with ventricular arrhythmias, sudden
cardiac death or transmural ischemia in which case revascu-
larization is needed [1–4]. In a recent study of 326 patients with
ACS, SCAD accounted for 4% of ACS [6], but in younger females
the prevalence of SCAD can be as high as 35% [1]. Although
the detection rate of SCAD has increased in the last decade
given increased awareness and improved endovascular imaging
techniques, namely, intravascular ultrasound and optical
coherence tomography [6], SCAD is likely still underdiagnosed
due to misinterpreting intramural hematoma as spasm or
atherosclerotic plaque during angiography and misdiagnosing
young female’s chest pain as non-cardiac [3].
Sarcoidosis is a systemic, granulomatous inflammatory
disease, which can manifest with solely cardiac symptoms [7].
The four most common manifestations of cardiac sarcoidosis
(CS) are heart block, ventricular arrhythmias, heart failure and
sudden cardiac death. Granulomas can involve any part of the
heart, including the coronary arteries [4, 5, 8–10]. In the literature,
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Table 1: CS registry patient characteristics
Finnish CS Registry (MIDFIN)∗ Ottawa CS Registry∗
Age at diagnosis (mean ± SD, min–max), years 53 ± 12 (18–85) 55 ± 10 (29–74)
Gender, female N (%) 283 (71%) 31 (39%)
Presentation, N (%)
Clinically manifest∗∗
Heart block
Ventricular arrhythmia
LV dysfunction
Aborted SCD
Fatal SCD
Other
Clinically silent∗∗∗
401
193/401 (48%)
47/401 (12%)
57/401 (14%)
15/401 (4%)
38/401 (9%)
51/401 (13%)
0
48
27/48 (56%)
8/48 (17%)
9/48 (19%)
0
0
4/48 (8%)
32
Follow-up time (median, range), months 43 (0.1–306) 48 (11–97)
CS = cardiac sarcoidosis, LV = left ventricle, SCD= sudden cardiac death, SCAD = spontaneous coronary artery dissection.
∗Prospective clinical registries of CS patients in Finland and Ottawa region. MIDFIN also includes autopsy data on all patients with CS as a likely cause of death. All
autopsies included examination of the coronary arteries. The Ottawa data is part of the Multi-center Canadian/Japanese Cardiac Sarcoidosis Cohort Study (CHASM-CS
NCT01477359)
∗∗Clinically manifest CS; patients who presented with cardiac symptoms and were diagnosed with CS based on cardiac imaging and cardiac or extra-cardiac histology.
∗∗∗Clinically silent CS; patients who presented with extra-CS and were found asymptomatic cardiac involvement on imaging screening.
sarcoidosis is listed among the potential differential etiologies
of SCAD, yet its frequency in the causal spectrum of SCAD has
not been described before [1, 2]. Here we present a case of
relapsing CS presenting with SCAD. Further, we report results
from two prospective CS registries to demonstrate the rarity of
SCAD in CS.
CASE REPORT
The baseline characteristics of the two CS registry populations
are shown in Table 1. A total of 481 patients were followed for
a median follow-up was 3.7 years with a total of ≈1800 years
of patient follow-up. There was a single report of SCAD from
the Ottawa registry and none from the Finnish registry, which
included 38 patients with sudden cardiac death as the first
manifestation of CS.
A 61-year-old female with no conventional CV risk factors
initially presentedwith ventricular tachycardia and intermittent
complete heart block and was diagnosed with cardiac and
pulmonary sarcoidosis in July 2012. Cardiac magnetic resonance
imaging, whole body fluorodeoxyglucose positron emission
tomography (FDG-PET) and chest CT findings were consistent
with active sarcoid inflammation in myocardium, lungs and
mediastinal and hilar lymph nodes. Endomyocardial biopsy
confirmed sarcoid granuloma in one of the six biopsy samples
taken. Echocardiography showed low normal LVEF of 50% with
mild inferior hypokinesia. Coronary angiography showed no
significant stenoses in July 2012. The patient was treated with
Prednisone 50 mg with tapering doses and Methotrexate 15 mg
weekly started a few months later. Dual chamber ICD was
implanted for secondary prevention and she subsequently
had multiple appropriate ICD shocks. She also developed
persistent atrial fibrillation in July 2014. FDG-PET scan in
November 2014 showed no active CS (Fig. 1A). At that time,
she was only on Prednisone 5 mg daily which was needed
due to adrenal insufficiency diagnosed while on steroid taper
in 2013. Echocardiography in February 2015 showed LVEF
of 50–55%.
In November 2015, she presented with 7/10 retrosternal chest
pain that persisted for an hour. Troponin I rose from 0.127
Figure 1:Whole body FDG-PET images (upper panels) and 4HC transaxial views of
fused FDG-PET/CT thorax images (lower panels). Scan 1A upper panel: no cardiac
or mediastinal FDG uptake. Scan 1A lower panel: no FDG uptake. Scan 1B upper
panel: increased FDG uptake in mediastinal and hilar lymph nodes, basal to mid
inferior wall and basal to mid anterior wall. Scan 1B lower panel: increased FDG
uptake in the basal to mid inferior septum and lateral wall.
up to 2.206 (reference limit <0.045 ug/L) and CK peaked at 77.
Chest CT showed no evidence of pulmonary embolism or aortic
dissection. She underwent coronary angiography that revealed a
90%distal circumflex lesion (LCX) and 90%diffuse right posterior
descending artery lesion that were consistent with SCAD. There
was intramural dye hang-up in the distal LCX due to coronary
wall tear (Fig. 2A). The patient was hemodynamically stable and
no coronary procedures were done.
A FDG-PET scan (preceded by similar sarcoid diet prepa-
ration as in previous scans) showed increased FDG uptake in
inferior and septal walls, being most prominent in the septum,
not following the coronary territories and an inferior perfusion
defect (Fig. 1B). The FDG-PET findings were best in keeping
with recurrent active sarcoidosis and treated as such although
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Figure 2: (A) Showing mural dye hung-up in the distal LCX due to mural hematoma. (B) Showing complete resolution of the LCX lesion.
less likely they could have reflected post myocardial infarction
stunning/hibernation. Methotrexate was restarted, Prednisone
dose was increased to 20 mg daily and Clopidogrel 75 mg and
ASA 81mgwere initiated. Coronary angiographywas repeated in
April 2016 and showed complete resolution of the right coronary
artery and LCX lesions (Fig. 2B). Kidney and peripheral vascula-
ture was normal. The appearance of the coronaries and natural
historywere considered consistentwith SCADwith spontaneous
healing. Since the SCAD in November 2015, the patient has
been stable with no arrhythmias, chest pain or heart failure
exacerbations. Last echocardiography in November 2017 showed
LVEF of 47% and TnI has been negative (<15 ng/L).
DISCUSSION
From two prospective CS registries involving 481 patients, we
found only a single case of SCAD.We believe that this is the first
report of CS presumably contributing to SCAD occurrence in a
living patient. It demonstrates a two-vessel SCAD in a biopsy-
confirmed CS patient, most likely as a presentation of relapsing
disease. Although the likelihood of coincidence of the two rare
conditions is minimal, it cannot be ruled out definitely. The
SCAD diagnosis was based on angiogram findings. In the CS
registries, patients did not routinely undergo angiography at
initial diagnosis; however, theses were performed depending
on particular presenting features, e.g. for cardiomyopathy,
ventricular arrhythmias or chest pain. The patient in this
report had a normal coronary angiogram at initial presentation.
Further, in the post-mortem-diagnosed patients, the coroner
studied the coronaries with no signs of SCAD in any of the
38 patients.
The two previous case reports described autopsy cases with
histopathological proof of sarcoidosis affecting the coronary
arteries [4, 5]. The first case was a postpartum female with
multi-vessel chronic and acute SCAD leading to sudden death
caused by arrhythmia [4]. The second case was an acute SCAD
causing cardiac tamponade and death secondary to previously
undiagnosed CS in a male [5].
The vascular involvement in CS can be complex. It is now
apparent that CS entails tissue level changes beyond focal areas
of granuloma and scar [11, 12]. Early radionuclide studies showed
perfusion abnormalities with reverse distribution (i.e. the pres-
ence of a perfusion defect at rest that decreases or disappears
under stress, contrary to what happens in ischemia) in sys-
temic sarcoidosis patients, implying a microvascular dysfunc-
tion mechanism, hypothesized to be due to focal reversible
vasoconstriction in arterioles adjacent to sarcoid granulomas
[13]. On the other hand, a recent study demonstrated normal
myocardial blood flow at rest but reduced hyperemic blood flow
parameters locally in inflamed myocardium and in advanced
disease even outside the inflamed regions [12]. Although some-
what contradictory at amechanistic level, these findings suggest
a diffuse impairment of coronary circulation in some patients
with CS. In keeping with this, from histopathological studies, it
is known that the granulomas can locally afflict the coronaries
with granulomas found within atherosclerotic plaques [10], in
the arterial media and in the adventitia, but also wider spread
vascular inflammation similar to vasculitis has been reported
[5, 8, 9]. Furthermore, one possible link between CS and SCAD is
the collagenolytic and cytotoxic effect of eosinophils. In the two
previous case reports, autopsy showed infiltrates of eosinophlis
andmononuclear cells at the involved areas [4, 5]. Periadventitial
eosinophilic infiltrates have also been observed in autopsies of
peripartum women [14]. It is believed that these eosinophilic
granules cause breakdown of the medial–adventitial layer via
lytic substances, predisposing the artery to dissection. However,
it is unclear whether the eosinophilic granules cause SCAD
or are reactive to a nonspecific response to vascular injury in
SCAD.
CS is increasingly recognized as a cause of diverse cardiac
manifestations. Sarcoidosis has been previously introduced as
one of the differential diagnoses of SCAD, yet its prevalence
in the causal spectrum of SCAD has not been described
before. This report shows that manifest SCAD in CS is rare
(1/481 cases from two large CS registries). Physicians should
be aware that CS can present with SCAD. Also importantly,
our case showed that reactivation of active CS can present
with SCAD.
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